ramucirumab,pembrolizumab
eli lilly,merck
['lung', 'sclc', 'nsclc', 'ramucirumab', 'pembrolizumab']
#cedarssinaicancer at #asco22. today at 12:12pm pdt, dr. karen reckamp will present her work examining ramucirumab + pembrolizumab for advanced non small cell lung cancer treated with #immunotherapy. #nsclc 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.